WAM
WFA Asset Management’s Alnylam Pharmaceuticals ALNY Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.4K | Hold |
14
| – | – | ﹤0.01% | 184 |
|
|
2025
Q1 | $2.09K | Hold |
14
| – | – | ﹤0.01% | 213 |
|
|
2024
Q4 | $3.3K | Hold |
14
| – | – | ﹤0.01% | 202 |
|
|
2024
Q3 | $3.85K | Hold |
14
| – | – | ﹤0.01% | 174 |
|
|
2024
Q2 | $3.4K | Hold |
14
| – | – | ﹤0.01% | 185 |
|
|
2024
Q1 | $2.09K | Hold |
14
| – | – | ﹤0.01% | 214 |
|
|
2023
Q4 | $2.68K | Hold |
14
| – | – | ﹤0.01% | 201 |
|
|
2023
Q3 | $2.48K | Hold |
14
| – | – | ﹤0.01% | 212 |
|
|
2023
Q2 | $2.66K | Hold |
14
| – | – | ﹤0.01% | 214 |
|
|
2023
Q1 | $2.81K | Hold |
14
| – | – | ﹤0.01% | 214 |
|
|
2022
Q4 | $3.33K | Hold |
14
| – | – | ﹤0.01% | 194 |
|
|
2022
Q3 | $2.8K | Hold |
14
| – | – | ﹤0.01% | 212 |
|
|
2022
Q2 | $2.04K | Hold |
14
| – | – | ﹤0.01% | 204 |
|
|
2022
Q1 | $2.29K | Hold |
14
| – | – | ﹤0.01% | 188 |
|
|
2021
Q4 | $2.38K | Buy |
+14
| New | +$2.38K | ﹤0.01% | 171 |
|